P Maroto

Summary

Affiliation: Hospital de la Santa Creu i Sant Pau
Country: Spain

Publications

  1. ncbi request reprint Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
    P Maroto
    The Spanish Germinal Group, Spain
    Ann Oncol 16:1915-20. 2005
  2. ncbi request reprint Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
    J Aparicio
    Hospital Universitario La Fe, Valencia, Spain
    Ann Oncol 14:867-72. 2003
  3. ncbi request reprint [Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients]
    J R Germa
    Servicio de Oncología Médica Institut Català d Oncologia, Institut Catala d Oncologia, Avda Gran Via, S N, Km 2, 7 Barcelona
    Med Clin (Barc) 116:481-6. 2001
  4. ncbi request reprint Fungal infections in patients with solid tumors treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    J Montesinos
    Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 20:569-72. 2001
  5. pmc Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
    X Garcia del Muro
    Institut Catala d Oncologia, Department of Medical Oncology, Avda Gran Via Km 2 7, 08907 L Hospitalet, Barcelona, Spain
    Br J Cancer 86:326-30. 2002
  6. ncbi request reprint Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)
    J R Germa-Lluch
    Department of Medical Oncology, Institut Catala d Oncologia, Hospital Duran y Reynals, Av Gran Via S N, Km 2, 7, 08907 Hospitalet, Barcelona, Spain
    Eur Urol 42:553-62; discussion 562-3. 2002
  7. ncbi request reprint Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
    J Bellmunt
    Medical Oncology Service, Hospital General Universitari Vall d Hebron, Barcelona, Spain
    Ann Oncol 17:v113-7. 2006

Collaborators

  • J Aparicio
  • Joan Carles
  • Joaquim Bellmunt
  • Xavier Garcia del Muro
  • J R Germa-Lluch
  • J A Arranz
  • E Alba
  • J Guma
  • A Fernandez
  • J Sastre
  • A Saenz
  • J Montesinos
  • J R Germa
  • M A Climent
  • A Barnadas
  • X Perez
  • J Terrassa
  • L Paz-Ares
  • M A Sanchez
  • D Almenar
  • R Lasso de la Vega
  • M Lopez-Brea
  • G Berenguer
  • B Pardo
  • J Terrasa
  • R Salazar
  • M Gurgui
  • P Lianes
  • C Sola

Detail Information

Publications7

  1. ncbi request reprint Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
    P Maroto
    The Spanish Germinal Group, Spain
    Ann Oncol 16:1915-20. 2005
    ..The Spanish Germ Cell Group is composed of 60 centres. Our challenge was to define a surveillance protocol that would be safe and suitable regardless of population size or geographic coverage...
  2. ncbi request reprint Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
    J Aparicio
    Hospital Universitario La Fe, Valencia, Spain
    Ann Oncol 14:867-72. 2003
    ..This study was performed to assess a dual policy of surveillance and selective single-agent carboplatin (for high-risk cases) in a multicenter setting...
  3. ncbi request reprint [Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients]
    J R Germa
    Servicio de Oncología Médica Institut Català d Oncologia, Institut Catala d Oncologia, Avda Gran Via, S N, Km 2, 7 Barcelona
    Med Clin (Barc) 116:481-6. 2001
    ..Spanish Germ Cell Cancer Group (GG) joins the efforts of 51 different Spanish centres to share their experience on the diagnosis and treatment of these special tumours...
  4. ncbi request reprint Fungal infections in patients with solid tumors treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    J Montesinos
    Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 20:569-72. 2001
    ..Systemic antifungal prophylaxis does not seem to be justified for patients with solid tumors and autologous peripheral blood stem cell transplantation. Empiric amphotericin B may be safely started at day 7 of febrile neutropenia...
  5. pmc Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
    X Garcia del Muro
    Institut Catala d Oncologia, Department of Medical Oncology, Avda Gran Via Km 2 7, 08907 L Hospitalet, Barcelona, Spain
    Br J Cancer 86:326-30. 2002
    ..Docetaxel plus cisplatin is an effective and well-tolerated regimen for the treatment of advanced urothelial cancer, and warrants further investigation...
  6. ncbi request reprint Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)
    J R Germa-Lluch
    Department of Medical Oncology, Institut Catala d Oncologia, Hospital Duran y Reynals, Av Gran Via S N, Km 2, 7, 08907 Hospitalet, Barcelona, Spain
    Eur Urol 42:553-62; discussion 562-3. 2002
    ....
  7. ncbi request reprint Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
    J Bellmunt
    Medical Oncology Service, Hospital General Universitari Vall d Hebron, Barcelona, Spain
    Ann Oncol 17:v113-7. 2006
    ..There is an obvious need to incorporate in clinical trials a systematic translational approach to explain both our successes and our failures...